Logo image of NCV

VIRTUS CONVERTIBLE & INCOME (NCV) Stock Price, Quote, News and Overview

NYSE:NCV - New York Stock Exchange, Inc. - US92838X1028 - Currency: USD

13.77  -0.16 (-1.15%)

After market: 13.77 0 (0%)

Fundamental Rating

1

NCV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NCV has a bad profitability rating. Also its financial health evaluation is rather negative. NCV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NCV had positive earnings in the past year.
In multiple years NCV reported negative net income over the last 5 years.
NCV had negative operating cash flow in 4 of the past 5 years.
NCV Yearly Net Income VS EBIT VS OCF VS FCFNCV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 1.22%
ROE 1.51%
ROIC 1.92%
ROA(3y)0.72%
ROA(5y)0.79%
ROE(3y)-0.8%
ROE(5y)-0.1%
ROIC(3y)2.3%
ROIC(5y)3.19%
NCV Yearly ROA, ROE, ROICNCV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

NCV's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of NCV has declined.
NCV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 54.44%
PM (TTM) 27.76%
GM 56.89%
OM growth 3Y-14.92%
OM growth 5Y-9.87%
PM growth 3Y-42.16%
PM growth 5Y-27.95%
GM growth 3Y-15.54%
GM growth 5Y-10.23%
NCV Yearly Profit, Operating, Gross MarginsNCV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, NCV has about the same amount of shares outstanding.
NCV has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NCV has been reduced compared to a year ago.
NCV Yearly Shares OutstandingNCV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NCV Yearly Total Debt VS Total AssetsNCV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

NCV has an Altman-Z score of 1.05. This is a bad value and indicates that NCV is not financially healthy and even has some risk of bankruptcy.
NCV has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACCN/A
WACCN/A
NCV Yearly LT Debt VS Equity VS FCFNCV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.73 indicates that NCV may have some problems paying its short term obligations.
A Quick Ratio of 0.73 indicates that NCV may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
NCV Yearly Current Assets VS Current LiabilitesNCV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.29% over the past year.
The earnings per share for NCV have been decreasing by -41.60% on average. This is quite bad
NCV shows a decrease in Revenue. In the last year, the revenue decreased by -3.61%.
The Revenue for NCV have been decreasing by -18.53% on average. This is quite bad
EPS 1Y (TTM)103.29%
EPS 3Y-55.73%
EPS 5Y-41.6%
EPS Q2Q%-155.9%
Revenue 1Y (TTM)-3.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-18.53%
Sales Q2Q%-2.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCV Yearly Revenue VS EstimatesNCV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NCV Yearly EPS VS EstimatesNCV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 459.00, which means the current valuation is very expensive for NCV.
Compared to an average S&P500 Price/Earnings ratio of 29.53, NCV is valued quite expensively.
Industry RankSector Rank
PE 459
Fwd PE N/A
NCV Price Earnings VS Forward Price EarningsNCV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCV Per share dataNCV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

NCV has a Yearly Dividend Yield of 4.15%, which is a nice return.
NCV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

NCV has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NCV Yearly Dividends per shareNCV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NCV Yearly Income VS Free CF VS DividendNCV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

More info and screens

VIRTUS CONVERTIBLE & INCOME

NYSE:NCV (2/24/2025, 8:04:00 PM)

After market: 13.77 0 (0%)

13.77

-0.16 (-1.15%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners24.84%
Inst Owner Change-82.31%
Ins Owners0.01%
Ins Owner Change0%
Market Cap311.06M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0.47
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-13 2025-03-13 (0.136)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 459
Fwd PE N/A
P/S 12.5
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)0.03
EY0.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.1
BVpS20.28
TBVpS20.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.22%
ROE 1.51%
ROCE 2.58%
ROIC 1.92%
ROICexc 2%
ROICexgc 2%
OM 54.44%
PM (TTM) 27.76%
GM 56.89%
FCFM N/A
ROA(3y)0.72%
ROA(5y)0.79%
ROE(3y)-0.8%
ROE(5y)-0.1%
ROIC(3y)2.3%
ROIC(5y)3.19%
ROICexc(3y)2.32%
ROICexc(5y)3.2%
ROICexgc(3y)2.42%
ROICexgc(5y)3.37%
ROCE(3y)3.33%
ROCE(5y)4.37%
ROICexcg growth 3Y-26.44%
ROICexcg growth 5Y-17.32%
ROICexc growth 3Y-23.63%
ROICexc growth 5Y-17.32%
OM growth 3Y-14.92%
OM growth 5Y-9.87%
PM growth 3Y-42.16%
PM growth 5Y-27.95%
GM growth 3Y-15.54%
GM growth 5Y-10.23%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z 1.05
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.29%
EPS 3Y-55.73%
EPS 5Y-41.6%
EPS Q2Q%-155.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-18.53%
Sales Q2Q%-2.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.19%
EBIT growth 3Y-34.87%
EBIT growth 5Y-26.58%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A